0.86 USD
↗ 0.03 (4.12%)PRE MARKET (AS OF 04:58 AM EDT)
Onconetix, Inc. Common Stock
ONCONASDAQ • USD
Market: OPEN
ONCO is currently priced at $0.86. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, ONCO appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 24, 2026.
Open?$0.84
High?$0.86
Low?$0.81
Prev. Close?$0.82
Volume?630
Avg. Volume?824.1K
VWAP?$0.85
Rel. Volume?0.00x
Bid / Ask
Bid?$0.71 × 100
Ask?$0.96 × 100
Spread?$0.25
Midpoint?$0.83
Valuation & Ratios
Market Cap?3.0M
Shares Out?3.7M
Float?9.6M
Float %?83.9%
P/E Ratio?N/A
P/B Ratio?0.26
EPS?-$2.72
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Address
201 E. FIFTH STREET
CINCINNATI, OH 45202
Phone: 513-620-4101
CINCINNATI, OH 45202
Phone: 513-620-4101
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?65
Short Sent.?60
Piotroski F-Score?1/9Weak
Altman Z-Score?-15.49Distress
Confidence?52%Low
Short InterestLow
Short % of Float?1.27%Low
Short Interest?122.2K
Days to Cover?1.0
Free Float9.6M
Avg Daily Volume1.0M
Settlement Date2026-07-15
Financial Health
Current Ratio?1.41Adequate
Quick Ratio?1.37Adequate
Cash Ratio?1.21Strong
Debt/Equity?0.02Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?0.26CHEAP▾
Peers100
S&P97
P/S?4.12FAIR▾
Peers100
S&P37
P/FCF?N/A▾
EV/EBITDA?0.1CHEAP▾
Peers100
S&P97
EV/Sales?-0.60CHEAP▾
S&P97
Returns & Efficiency
ROE?-85.4%WEAK▾
S&P3
ROA?-67.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-441853
Fundamentals ratios updated end of day